Why is RPG LifeScience. falling/rising?

As of 02-Jul, RPG Life Sciences Ltd is currently priced at 2,507.70, reflecting a decrease of 46.8 points or 1.83%. Today's price summary indicates that the stock has underperformed its sector by 1.91% and has experienced a trend reversal, falling after two consecutive days of gains. The stock reached an intraday low of Rs 2,468.5, which represents a decline of 3.37%. Despite this recent downturn, RPG Life Sciences has shown strong performance over the past year, with a return of 55.88%, and has consistently outperformed the BSE500 in the last three annual periods. The company also boasts high management efficiency, indicated by a return on equity (ROE) of 20.39%, and a low debt-to-equity ratio, which supports its stability.
In the broader market context, RPG Life Sciences has demonstrated a solid return of 14.85% over the past month, significantly outperforming the Sensex, which only gained 2.50% in the same period. This trend is consistent with its year-to-date performance of 13.74% compared to the Sensex's 6.75%. The stock's strong historical returns over three and five years, at 348.64% and 833.10% respectively, further highlight its resilience. However, the recent decline may be attributed to short-term profit-taking after a period of gains, despite rising investor participation and liquidity, which suggests that the stock remains attractive for long-term investors.